|
April 22, 2022 |
April 21, 2022 |
B
Purchase
|
Epstein David R
Non-Executive Director
|
30,000
+0.6%
1.44
43,329
USD
|
30,000
+0.6%
|
1.44
|
43,329
USD
|
|
|
March 23, 2021 |
March 19, 2021 |
B
Purchase
|
Flagship Ventures Fund IV General Partner LLC
Major owner
|
70,000
+2.7%
29.00
2,030,000
USD
|
70,000
+2.7%
|
29.00
|
2,030,000
USD
|
|
|
March 23, 2021 |
March 19, 2021 |
B
Purchase
|
Flagship Ventures Fund IV General Partner LLC
Major owner
|
70,000
+1.2%
29.00
2,030,000
USD
|
70,000
+1.2%
|
29.00
|
2,030,000
USD
|
|
|
March 23, 2021 |
March 19, 2021 |
B
Purchase
|
Flagship Ventures Fund IV General Partner LLC
Major owner
|
70,000
+0.5%
29.00
2,030,000
USD
|
70,000
+0.5%
|
29.00
|
2,030,000
USD
|
|
|
March 15, 2021 |
March 15, 2021 |
PS
Planned sale
|
Keson-Brookes Maiken
CLO & Corp. Secretary
Officer
|
25,000
-100.0%
20.24
505,965
USD
|
25,000
-100.0%
|
20.24
|
505,965
USD
|
|
|
Feb. 16, 2021 |
Feb. 11, 2021 |
PS
Planned sale
|
Epstein David R
Non-Executive Director
|
26,704
-0.6%
14.93
398,560
USD
|
26,704
-0.6%
|
14.93
|
398,560
USD
|
|
|
Feb. 10, 2021 |
Feb. 10, 2021 |
PS
Planned sale
|
Epstein David R
Non-Executive Director
|
7,404
-0.2%
14.79
109,525
USD
|
7,404
-0.2%
|
14.79
|
109,525
USD
|
|
|
Feb. 10, 2021 |
Feb. 9, 2021 |
PS
Planned sale
|
Epstein David R
Non-Executive Director
|
2,100
-0.0%
14.83
31,146
USD
|
2,100
-0.0%
|
14.83
|
31,146
USD
|
|
|
Feb. 10, 2021 |
Feb. 8, 2021 |
PS
Planned sale
|
Epstein David R
Non-Executive Director
|
89,233
-1.9%
14.88
1,328,117
USD
|
89,233
-1.9%
|
14.88
|
1,328,117
USD
|
|
|
April 24, 2020 |
April 22, 2020 |
B
Purchase
|
Coughlin Christina M.
Chief Medical Officer
Officer
|
19,000
+inf%
5.52
104,814
USD
|
19,000
+inf%
|
5.52
|
104,814
USD
|
|
|
April 15, 2020 |
April 14, 2020 |
B
Purchase
|
CAGNONI PABLO J
CEO and President
Executive Director
|
21,000
+inf%
4.70
98,694
USD
|
21,000
+inf%
|
4.70
|
98,694
USD
|
|
|
March 19, 2020 |
March 17, 2020 |
B
Purchase
|
Epstein David R
Non-Executive Director
|
5,000
+0.1%
3.76
18,800
USD
|
5,000
+0.1%
|
3.76
|
18,800
USD
|
|
|
March 17, 2020 |
March 13, 2020 |
B
Purchase
|
Epstein David R
Non-Executive Director
|
5,000
+0.1%
4.00
20,000
USD
|
5,000
+0.1%
|
4.00
|
20,000
USD
|
|
|
March 17, 2020 |
March 13, 2020 |
B
Purchase
|
Epstein David R
Non-Executive Director
|
5,000
+0.1%
3.82
19,100
USD
|
5,000
+0.1%
|
3.82
|
19,100
USD
|
|
|
Dec. 18, 2019 |
Dec. 16, 2019 |
PS
Planned sale
|
CARPENTER CHRISTOPHER L.
Chief Medical Officer
Officer
|
48,000
-57.9%
13.48
646,901
USD
|
48,000
-57.9%
|
13.48
|
646,901
USD
|
|
|
Oct. 17, 2019 |
Oct. 14, 2019 |
PS
Planned sale
|
LANGER ROBERT
|
7,500
-100.0%
8.52
63,875
USD
|
7,500
-100.0%
|
8.52
|
63,875
USD
|
|
|
Sept. 18, 2019 |
Sept. 17, 2019 |
PS
Planned sale
|
CARPENTER CHRISTOPHER L.
Chief Medical Officer
|
11,877
-25.4%
10.05
119,309
USD
|
11,877
-25.4%
|
10.05
|
119,309
USD
|
|
|
Sept. 18, 2019 |
Sept. 16, 2019 |
PS
Planned sale
|
CARPENTER CHRISTOPHER L.
Chief Medical Officer
|
36,123
-50.9%
10.13
365,897
USD
|
36,123
-50.9%
|
10.13
|
365,897
USD
|
|
|
July 17, 2019 |
July 15, 2019 |
PS
Planned sale
|
LANGER ROBERT
|
7,500
-100.0%
14.94
112,049
USD
|
7,500
-100.0%
|
14.94
|
112,049
USD
|
|
|
June 24, 2019 |
June 20, 2019 |
PS
Planned sale
|
CARPENTER CHRISTOPHER L.
Chief Medical Officer
|
243
-0.7%
13.93
3,386
USD
|
243
-0.7%
|
13.93
|
3,386
USD
|
|
|
June 19, 2019 |
June 19, 2019 |
PS
Planned sale
|
CARPENTER CHRISTOPHER L.
Chief Medical Officer
|
18,399
-34.6%
13.80
253,868
USD
|
18,399
-34.6%
|
13.80
|
253,868
USD
|
|
|
June 19, 2019 |
June 18, 2019 |
PS
Planned sale
|
CARPENTER CHRISTOPHER L.
Chief Medical Officer
|
10,858
-23.8%
14.27
154,958
USD
|
10,858
-23.8%
|
14.27
|
154,958
USD
|
|
|
June 19, 2019 |
June 17, 2019 |
PS
Planned sale
|
CARPENTER CHRISTOPHER L.
Chief Medical Officer
|
18,500
-34.7%
14.10
260,869
USD
|
18,500
-34.7%
|
14.10
|
260,869
USD
|
|
|
April 17, 2019 |
April 15, 2019 |
PS
Planned sale
|
LANGER ROBERT
|
7,500
-100.0%
17.57
131,799
USD
|
7,500
-100.0%
|
17.57
|
131,799
USD
|
|
|
April 10, 2019 |
April 8, 2019 |
PS
Planned sale
|
NISSEN TORBEN STRAIGHT
President
|
2,100
-0.1%
20.00
42,000
USD
|
2,100
-0.1%
|
20.00
|
42,000
USD
|
|
|
April 5, 2019 |
April 5, 2019 |
PS
Planned sale
|
NISSEN TORBEN STRAIGHT
President
|
12,096
-0.7%
20.00
241,920
USD
|
12,096
-0.7%
|
20.00
|
241,920
USD
|
|
|
April 5, 2019 |
April 3, 2019 |
PS
Planned sale
|
NISSEN TORBEN STRAIGHT
President
|
500
-0.0%
20.00
10,000
USD
|
500
-0.0%
|
20.00
|
10,000
USD
|
|
|
March 19, 2019 |
March 15, 2019 |
PS
Planned sale
|
CARPENTER CHRISTOPHER L.
Chief Medical Officer
|
48,000
-57.9%
15.84
760,114
USD
|
48,000
-57.9%
|
15.84
|
760,114
USD
|
|
|
Jan. 18, 2019 |
Jan. 14, 2019 |
PS
Planned sale
|
LANGER ROBERT
Non-Executive Director
|
7,500
-100.0%
14.59
109,444
USD
|
7,500
-100.0%
|
14.59
|
109,444
USD
|
|
|
July 23, 2018 |
July 20, 2018 |
B
Purchase
|
Pomerantz Roger
Non-Executive Director
|
100
+inf%
23.00
2,300
USD
|
100
+inf%
|
23.00
|
2,300
USD
|
|
|
July 23, 2018 |
July 20, 2018 |
B
Purchase
|
Sohn Catherine A.
Non-Executive Director
|
2,500
+inf%
23.00
57,500
USD
|
2,500
+inf%
|
23.00
|
57,500
USD
|
|
|
July 23, 2018 |
July 20, 2018 |
B
Purchase
|
Symonds Jonathan
Non-Executive Director
|
25,000
+inf%
23.00
575,000
USD
|
25,000
+inf%
|
23.00
|
575,000
USD
|
|
|
July 23, 2018 |
July 20, 2018 |
B
Purchase
|
Cuss Francis M
Non-Executive Director
|
10,000
+inf%
23.00
230,000
USD
|
10,000
+inf%
|
23.00
|
230,000
USD
|
|
